KIMBERLY LEYENDECKER: Open Payments
NPI 1063477685 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 23 payments from 8 companies in 2025. Trend: 2023 $552 · 2024 $477 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $159 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $109 |
| Astellas Pharma US Inc | 4 | $108 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| MILLICENT US INC | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Biogen, Inc. | 1 | $17 |
Products named: EVENITY, Veozah, MYFEMBREE, JOURNAVX, Mirena, FEMLYV, GEMTESA, FEMRING.
Industry payments across FL — which companies pay providers there.
